Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBioventus Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | $0.06 | $0.07 | $0.07 |
| Q2 2026 | 3 | $0.21 | $0.22 | $0.22 |
| Q3 2026 | 3 | $0.16 | $0.16 | $0.16 |
| Q4 2026 | 3 | $0.24 | $0.25 | $0.25 |
| Q1 2027 | 1 | $0.15 | $0.15 | $0.15 |
| Q2 2027 | 1 | $0.24 | $0.24 | $0.24 |
| Q3 2027 | 1 | $0.22 | $0.22 | $0.22 |
| Q4 2027 | 1 | $0.31 | $0.32 | $0.31 |
| Q1 2028 | 2 | $0.17 | $0.17 | $0.17 |
| Q2 2028 | 2 | $0.30 | $0.30 | $0.30 |
| Q3 2028 | 2 | $0.24 | $0.25 | $0.25 |
| Q4 2028 | 2 | $0.34 | $0.35 | $0.35 |
Bioventus Inc Earnings Date And Information
Bioventus Inc last posted its earnings results on Wednesday, August 5th, 2026. The company reported $0.22 earnings per share for the quarter, topping analysts' consensus estimates of $0.2163 by $0.0037. The company had revenue of 153.21 M for the quarter and had revenue of 568.09 M for the year. Bioventus Inc has generated $0 earnings per share over the last year ($0.33 diluted earnings per share) and currently has a price-to-earnings ratio of 17.9. Bioventus Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Bioventus Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/05/2026 | Q2 2026 | $0.22 | $0.49 | 0.27 | $155.44 M | $153.21 M |
| 05/06/2026 | Q1 2026 | $0.09 | $0.05 | -0.04 | $129.92 M | $132.09 M |
| 03/05/2026 | Q4 2025 | $0.22 | $0.22 | 0 | $154.95 M | $157.90 M |
| 11/04/2025 | Q3 2025 | $0.22 | $0.05 | -0.17 | $138.19 M | $138.65 M |
| 08/06/2025 | Q2 2025 | $0.22 | $0.11 | -0.11 | $145.86 M | $147.66 M |
| 05/06/2025 | Q1 2025 | $0.06 | -$0.04 | -0.1 | $122.71 M | $123.88 M |
| 03/11/2025 | Q4 2024 | $0.08 | -$0.00 | -0.08 | $145.16 M | $153.64 M |
| 11/05/2024 | Q3 2024 | $0.06 | -$0.07 | -0.13 | $133.24 M | $138.96 M |
| 08/06/2024 | Q2 2024 | $0.07 | -$0.37 | -0.44 | $137.60 M | $151.22 M |
| 05/07/2024 | Q1 2024 | -$0.05 | -$0.08 | -0.03 | $118.37 M | $129.46 M |
| 03/12/2024 | Q4 2023 | $0.06 | -$0.10 | -0.16 | $123.96 M | $135.42 M |
| 11/07/2023 | Q3 2023 | $0.06 | -$0.12 | -0.18 | $119.00 M | $120.79 M |
| 08/08/2023 | Q2 2023 | $0.03 | -$0.06 | -0.09 | $129.23 M | $137.07 M |
| 05/16/2023 | Q1 2023 | -$0.11 | -$2.24 | -2.13 | $116.57 M | $119.06 M |
| 03/31/2023 | Q4 2022 | $0.05 | -$0.52 | -0.57 | $132.59 M | $125.83 M |
| 11/21/2022 | Q3 2022 | N/A | -$1.76 | N/A | $141.60 M | $128.66 M |
| 08/12/2022 | Q2 2022 | N/A | -$0.11 | N/A | $138.33 M | $140.33 M |
| 05/11/2022 | Q1 2022 | N/A | -$0.19 | N/A | $117.69 M | $117.29 M |
| 03/11/2022 | Q4 2021 | N/A | -$0.01 | N/A | $130.23 M | $130.41 M |
| 11/10/2021 | Q3 2021 | N/A | -$0.03 | N/A | $102.39 M | $108.89 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bioventus Inc Earnings: FAQ's
In the previous quarter, Bioventus Inc (:BVS) reported $0.22 earnings per share (EPS) to beat the analysts' consensus estimate of $0.2163 by $0.0037.
The conference call for Bioventus Inc's latest earnings report can be listened to online.
The conference call transcript for Bioventus Inc's latest earnings report can be read online.
Bioventus Inc (:BVS) has a recorded annual revenue of $568.09 M.
Bioventus Inc (:BVS) has a recorded net income of $22.73 M.Bioventus Inc has generated $0.34 earnings per share over the last four quarters.
Bioventus Inc (:BVS) has a price-to-earnings ratio of 17.9 and price/earnings-to-growth ratio is 0.